CVRx, Inc.(CVRX),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community

At the request of the exchanges, the U.S./Hong Kong stock quotes are displayed on a 15-minute delay, download the APP to view the real-time quotes for free.

Close

CVRX CVRx, Inc.

Not Yet Opened 12-22 16:00:00 EST

7.82

-0.21

-2.62%

盘后7.82

+0.000.00%

18:26 EST

High7.90	Low7.14	Vol383.29K
Open7.80	D1 Closing8.03	Amplitude9.46%
Mkt Cap204.96M	Tradable Cap140.48M	Total Shares26.21M
T/O2.94M	T/O Rate2.13%	Tradable Shares17.96M
P/B--	ROE--	EPS0.00
52wk High--	52wk Low--	P/E--
Dividend--	Div.Yield--	ROA--

Loading ...

{"stockData":{"symbol":"CVRX","market":"US","secType":"STK","nameCN":"CVRx, Inc.","latestPrice":7.82,"timestamp":1766437200000,"preClose":8.03,"halted":0,"volume":383294,"hourTrading":{"tag":"盘后","latestPrice":7.82,"preClose":7.82,"latestTime":"18:26 EST","volume":19,"amount":151.1708,"timestamp":1766445979312},"delay":0,"floatShares":17964079,"shares":26210109,"eps":-2.023251,"marketStatus":"Not Yet Opened","change":-0.21,"latestTime":"12-22 16:00:00 EST","open":7.8,"high":7.9,"low":7.14,"amount":2940974.61613,"amplitude":0.094645,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":0,"etf":0,"ttmEps":-2.023251,"tradingStatus":0,"nextMarketStatus":{"tag":"Pre-Mkt","tradingStatus":1,"beginTime":1766480400000},"marketStatusCode":0,"adr":0,"listingDate":1625025600000,"exchange":"NASDAQ","adjPreClose":8.03,"preHourTrading":{"tag":"盘前","latestPrice":7.79,"preClose":8.03,"latestTime":"09:29 EST","volume":489,"amount":3799.8599283,"timestamp":1766413799999},"postHourTrading":{"tag":"盘后","latestPrice":7.82,"preClose":7.82,"latestTime":"18:26 EST","volume":19,"amount":151.1708,"timestamp":1766445979312},"volumeRatio":2.247207,"impliedVol":1.4851,"impliedVolPercentile":0.844},"requestUrl":"/m/hq/s/CVRX/tweets","defaultTab":"tweets","newsList":[{"id":"2593143383","title":"CVRx to Present at the 44th Annual J.P. Morgan Healthcare Conference","url":"https://stock-news.laohu8.com/highlight/detail?id=2593143383","media":"GlobeNewswire","labels":["conferences"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2593143383?lang=en_us&edition=fundamental","pubTime":"2025-12-22 21:30","pubTimestamp":1766410200,"startTime":"0","endTime":"0","summary":"MINNEAPOLIS, Dec.  22, 2025  (GLOBE NEWSWIRE) -- CVRx, Inc. (NASDAQ: CVRX) (\"CVRx\"), a commercial-stage medical device company focused on developing, manufacturing and commercializing innovative neuro","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2025/12/22/3209222/0/en/CVRx-to-Present-at-the-44th-Annual-J-P-Morgan-Healthcare-Conference.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"conferences","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4082","LU0128526141.USD","LU0795875086.SGD","BK4581","LU1162221912.USD","CVRX","LU0098860793.USD","IE00BZ1G4Q59.USD","LU0158827781.USD","LABU","LU1074936037.SGD","BK4534","LU1668664300.SGD","LU1720051108.HKD","PT","LU0106261372.USD","HCSG","LU2347655156.SGD","BK4137","LU1989772923.USD","LU2023251221.USD","LU1989772840.SGD","LU0234570918.USD","LU2028103732.USD","LU2133065610.SGD","LU1244550494.USD","LU1732799900.SGD","LU2357305700.SGD","LU2111349929.HKD","LU2089284900.SGD","BK4539","BK4166","BK4504","LU2271345857.HKD","IE00BKVL7J92.USD","BK4516","LU1720051017.SGD","LU0158827948.USD","LU0029874061.USD","LU0795875169.SGD","LU0528227936.USD","LU0912757837.SGD","XBI","BK4588","LU1244550221.USD","XLV","LU0320765646.SGD","LU0267386448.USD","LU1548497426.USD","LU0106831901.USD"],"gpt_icon":0},{"id":"2588770809","title":"Johnson & Johnson Reports Disposal of CVRx Inc. Common Shares","url":"https://stock-news.laohu8.com/highlight/detail?id=2588770809","media":"Reuters","labels":["shareholding","insiderTrades","express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2588770809?lang=en_us&edition=fundamental","pubTime":"2025-12-02 05:08","pubTimestamp":1764623282,"startTime":"0","endTime":"0","summary":"Johnson & Johnson, as a 10% beneficial owner, reported the disposal of common shares of CVRx Inc. The filing was submitted by Johnson & Johnson and other reporting beneficial owners. The full filing can be accessed through the link below.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. CVRx Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission , on December 01, 2025, and is solely responsible for the information contained therein.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251201:nNDL39Ctdc:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding,insiderTrades,express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU1894683264.USD","LU0889566641.SGD","IE00B3T34201.USD","LU1914381329.SGD","IE000M9KFDE8.USD","BK4533","LU2505996681.GBP","BK4550","CVRX","IE00BLSP4239.USD","LU0070217475.USD","IE00BDGV0183.EUR","IE00BSNM7G36.USD","LU1196500208.SGD","LU1496350502.SGD","LU1585245621.USD","LU0792757196.USD","LU1244550221.USD","BK4568","LU1674673691.USD","LU1778281490.HKD","LU0345770993.USD","JNJ","LU2471134796.USD","LU1032466523.USD","LU0234572021.USD","IE00BJT1NW94.SGD","IE00BVYPNV92.GBP","IE00B19Z3B42.SGD","LU0345769631.USD","IE00BLSP4452.SGD","LU1066051811.HKD","LU1244550494.USD","SG9999001440.SGD","BK4585","LU2750360641.GBP","BK4007","IE00BBT3K403.USD","BK4082","LU1061106388.HKD","LU1732799900.SGD","LU1280957306.USD","LU2112291526.USD","BK4532","LU0058720904.USD","LU1261432733.SGD","LU2133065610.SGD","LU0098860793.USD","BK4534","LU1935042991.SGD"],"gpt_icon":0},{"id":"2586086934","title":"Johnson & Johnson Reports Disposal of CVRx Inc. Common Shares","url":"https://stock-news.laohu8.com/highlight/detail?id=2586086934","media":"Reuters","labels":["shareholding","insiderTrades","express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2586086934?lang=en_us&edition=fundamental","pubTime":"2025-11-26 01:54","pubTimestamp":1764093296,"startTime":"0","endTime":"0","summary":"Johnson & Johnson has reported the disposal of common shares of CVRx Inc. , according to a recent SEC filing. The transaction was filed by Johnson & Johnson and Johnson & Johnson Innovation - JJDC, Inc., among other reporting beneficial owners. The full filing can be accessed through the link below.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. CVRx Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission , on November 25, 2025, and is solely responsible for the information contained therein.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251125:nNDLbmB4GQ:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding,insiderTrades,express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0070217475.USD","BK4007","BK4588","LU1023059063.AUD","LU1261432733.SGD","IE00B1BXHZ80.USD","LU1244550494.USD","BK4532","LU0345769631.USD","IE0002141913.USD","LU0889566641.SGD","LU1894683348.USD","BK4534","CVRX","IE00B7SZLL34.SGD","LU1196500208.SGD","LU2471134523.USD","LU2592432038.USD","LU2133065610.SGD","LU1162221912.USD","LU1221951129.SGD","LU1066053197.SGD","LU2750360997.AUD","IE00BJJMRZ35.SGD","LU0098860793.USD","LU1066051225.USD","LU1914381329.SGD","LU0882574055.USD","LU2347655156.SGD","LU1221951046.USD","LU2750360641.GBP","JNJ","LU2602419157.SGD","SG9999002232.USD","BK4539","IE00B4R5TH58.HKD","BK4585","IE00B3PB1722.GBP","LU1244550221.USD","BK4550","IE00BFTCPJ56.SGD","LU0345770993.USD","LU1430594728.SGD","LU0795875169.SGD","LU1929549753.HKD","IE00BDGV0183.EUR","LU0289739699.SGD","LU2430703178.SGD","LU2471134796.USD","LU2430703095.HKD"],"gpt_icon":0},{"id":"2586842741","title":"CVRx (CVRX) Gets a Buy from Canaccord Genuity","url":"https://stock-news.laohu8.com/highlight/detail?id=2586842741","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2586842741?lang=en_us&edition=fundamental","pubTime":"2025-11-25 19:56","pubTimestamp":1764071810,"startTime":"0","endTime":"0","summary":"In a report released today, William Plovanic from Canaccord Genuity reiterated a Buy rating on CVRx, with a price target of $11.00. According to Ti...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/cvrx-cvrx-gets-a-buy-from-canaccord-genuity-blurbs-2?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/cvrx-cvrx-gets-a-buy-from-canaccord-genuity-blurbs-2?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["CVRX","BK4539","BK4082"],"gpt_icon":0},{"id":"2585115566","title":"Promising Future for CVRx: Buy Rating Supported by BENEFIT-HF Trial and Market Expansion","url":"https://stock-news.laohu8.com/highlight/detail?id=2585115566","media":"TIPRANKS","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2585115566?lang=en_us&edition=fundamental","pubTime":"2025-11-20 23:45","pubTimestamp":1763653541,"startTime":"0","endTime":"0","summary":"William Blair analyst Brandon Vazquez has maintained their bullish stance on CVRX stock, giving a Buy rating on November 6. Brandon Vazquez has giv...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/ratings/promising-future-for-cvrx-buy-rating-supported-by-benefit-hf-trial-and-market-expansion-ratings?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/ratings/promising-future-for-cvrx-buy-rating-supported-by-benefit-hf-trial-and-market-expansion-ratings?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["HF","CVRX"],"gpt_icon":0},{"id":"2584443959","title":"CVRx to Participate at the Piper Sandler 37th Annual Healthcare Conference","url":"https://stock-news.laohu8.com/highlight/detail?id=2584443959","media":"GlobeNewswire","labels":["conferences"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2584443959?lang=en_us&edition=fundamental","pubTime":"2025-11-19 21:30","pubTimestamp":1763559000,"startTime":"0","endTime":"0","summary":"MINNEAPOLIS, Nov.  19, 2025  (GLOBE NEWSWIRE) -- CVRx, Inc. (NASDAQ: CVRX) (\"CVRx\"), a commercial-stage medical device company focused on developing, manufacturing and commercializing innovative neuro","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2025/11/19/3190925/0/en/CVRx-to-Participate-at-the-Piper-Sandler-37th-Annual-Healthcare-Conference.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"conferences","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4137","BK4082","LABU","XLV","BK4585","BK4590","HCSG","CVRX","ET","XBI","LU0128526141.USD","BK4561","BK4539","BK4588","LU0029874061.USD","BK4581","BK4144"],"gpt_icon":0},{"id":"2583636347","title":"Johnson & Johnson Makes a Bold Move with CVRx Shares!","url":"https://stock-news.laohu8.com/highlight/detail?id=2583636347","media":"TIPRANKS","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2583636347?lang=en_us&edition=fundamental","pubTime":"2025-11-15 10:11","pubTimestamp":1763172681,"startTime":"0","endTime":"0","summary":"New insider activity at CVRx ( ($CVRX) ) has taken place on November 14, 2025. Significant shareholder Johnson & Johnson has divested 1,000 shares ...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/insider-trading/johnson-johnson-makes-a-bold-move-with-cvrx-shares-insider-trading?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/insider-trading/johnson-johnson-makes-a-bold-move-with-cvrx-shares-insider-trading?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4532","IE000M9KFDE8.USD","LU1059921491.USD","LU1244550494.USD","IE00BBT3K403.USD","LU1506573853.SGD","IE00BDGV0183.EUR","LU0466842654.USD","LU2471134879.HKD","LU1778281490.HKD","LU2592432038.USD","BK4007","LU2430703178.SGD","BK4568","IE0002270589.USD","IE00B2B36J28.USD","LU1221951129.SGD","LU1267930813.SGD","IE00B4R5TH58.HKD","SG9999001440.SGD","IE00BGHQF631.EUR","LU2750360997.AUD","LU1430594728.SGD","IE00BSNM7G36.USD","LU2505996509.AUD","IE0002141913.USD","IE00BVYPNV92.GBP","IE00B3PB1722.GBP","LU0058720904.USD","LU1074936037.SGD","LU1496350502.SGD","JNJ","LU2129689431.USD","LU0792757196.USD","LU0795875169.SGD","LU2471134952.CNY","LU1066051811.HKD","LU2112291526.USD","LU0070217475.USD","LU0320765646.SGD","LU1732800096.USD","LU0889566641.SGD","LU1718418525.SGD","IE00B1BXHZ80.USD","LU1244550221.USD","BK4592","LU1244550577.SGD","LU1061106388.HKD","IE00BLSP4452.SGD","CVRX"],"gpt_icon":0},{"id":"2583689140","title":"Johnson & Johnson Reports Disposal of CVRx Inc. Common Shares","url":"https://stock-news.laohu8.com/highlight/detail?id=2583689140","media":"Reuters","labels":["shareholding","insiderTrades","express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2583689140?lang=en_us&edition=fundamental","pubTime":"2025-11-15 04:07","pubTimestamp":1763150861,"startTime":"0","endTime":"0","summary":"Johnson & Johnson has reported the disposal of common shares of CVRx Inc., according to a recent SEC filing. The transaction was reported jointly by Johnson & Johnson and Johnson & Johnson Innovation - JJDC, Inc., among other reporting beneficial owners. The full filing can be accessed through the link below.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. CVRx Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission , on November 14, 2025, and is solely responsible for the information contained therein.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251114:nNDL71pBJx:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding,insiderTrades,express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU1244550577.SGD","IE00B42XCP33.USD","JNJ","LU0795875169.SGD","LU2505996681.GBP","BK4585","LU1057294990.SGD","LU1244550221.USD","LU2129689514.USD","IE00BJJMRZ35.SGD","LU1023059063.AUD","LU1221951129.SGD","LU2471134879.HKD","LU0114720955.EUR","BK4532","LU0882574055.USD","LU0345770993.USD","LU1718418525.SGD","LU1196500208.SGD","LU2112291526.USD","SG9999001440.SGD","BK4533","LU1585245621.USD","LU2602419157.SGD","IE00BFTCPJ56.SGD","LU0070217475.USD","IE00B4R5TH58.HKD","LU0466842654.USD","LU0640476718.USD","LU2468319806.SGD","LU2750360641.GBP","IE00B19Z3581.USD","IE00BDGV0183.EUR","LU1066053197.SGD","LU1914381329.SGD","LU2471134952.CNY","LU2430703095.HKD","LU1059921491.USD","IE00BN8TJ469.HKD","LU1280957306.USD","IE00BSNM7G36.USD","LU1066051225.USD","LU0912757837.SGD","LU0289739699.SGD","LU2347655156.SGD","IE000M9KFDE8.USD","LU0345769631.USD","LU2505996509.AUD","LU1935042991.SGD","CVRX"],"gpt_icon":0},{"id":"2582024428","title":"Johnson & Johnson Reports Disposal of CVRx Inc. Common Shares","url":"https://stock-news.laohu8.com/highlight/detail?id=2582024428","media":"Reuters","labels":["insiderTrades"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2582024428?lang=en_us&edition=fundamental","pubTime":"2025-11-11 04:29","pubTimestamp":1762806577,"startTime":"0","endTime":"0","summary":"Johnson & Johnson reported a disposal of common shares of CVRx Inc. in a recent SEC filing. The transaction was filed by Johnson & Johnson Innovation - JJDC, Inc., along with other reporting beneficial owners. The full filing can be accessed through the link below.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. CVRx Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission , on November 10, 2025, and is solely responsible for the information contained therein.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251110:nNDL5sFwFg:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":"Johnson & Johnson Reports Disposal of CVRx Inc. Common Shares","news_tag":"insiderTrades","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4082","CVRX","BK4539"],"gpt_icon":0},{"id":"2581014997","title":"CVRx Is Maintained at Buy by Canaccord Genuity","url":"https://stock-news.laohu8.com/highlight/detail?id=2581014997","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2581014997?lang=en_us&edition=fundamental","pubTime":"2025-11-07 04:08","pubTimestamp":1762459680,"startTime":"0","endTime":"0","summary":"Ratings actions from Benzinga: https://www.benzinga.com/quote/CVRX/analyst-ratings \n\n\n \n\n\n  (END) Dow Jones Newswires\n\n\n  November 06, 2025 15:08 ET (20:08 GMT)","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["CVRX"],"gpt_icon":0},{"id":"2581301090","title":"CVRx (CVRX) Receives a Buy from Lake Street","url":"https://stock-news.laohu8.com/highlight/detail?id=2581301090","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2581301090?lang=en_us&edition=fundamental","pubTime":"2025-11-06 23:56","pubTimestamp":1762444580,"startTime":"0","endTime":"0","summary":"Lake Street analyst Frank Takkinen reiterated a Buy rating on CVRx today and set a price target of $14.00. According to TipRanks, Takkinen is a 3-s...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/cvrx-cvrx-receives-a-buy-from-lake-street-blurbs?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/cvrx-cvrx-receives-a-buy-from-lake-street-blurbs?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4539","BK4082","CVRX"],"gpt_icon":0},{"id":"2581109447","title":"CVRx Is Maintained at Overweight by Cantor Fitzgerald","url":"https://stock-news.laohu8.com/highlight/detail?id=2581109447","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2581109447?lang=en_us&edition=fundamental","pubTime":"2025-11-06 22:40","pubTimestamp":1762440000,"startTime":"0","endTime":"0","summary":"Ratings actions from Benzinga: https://www.benzinga.com/quote/CVRX/analyst-ratings \n\n\n \n\n\n  (END) Dow Jones Newswires\n\n\n  November 06, 2025 09:40 ET (14:40 GMT)","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["CVRX"],"gpt_icon":0},{"id":"2581099875","title":"BRIEF-CVRx May Offer And Sell Up To $150 Million In Securities - SEC Filing","url":"https://stock-news.laohu8.com/highlight/detail?id=2581099875","media":"Reuters","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2581099875?lang=en_us&edition=fundamental","pubTime":"2025-11-06 21:54","pubTimestamp":1762437265,"startTime":"0","endTime":"0","summary":"BRIEF-CVRx May Offer And Sell Up To $150 Million In Securities - SEC FilingNov 6 (Reuters) - CVRx Inc CVRX.O:CVRX INC - MAY OFFER AND SELL UP TO $150 MILLION IN SECURITIES - SEC FILINGSource text: [ID:n0001104659-25-107459]Further company coverage: CVRX.O ((Reuters.Briefs@thomsonreuters.com;))","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251106:nFWN3WI0ZY:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4082","BK4539","CVRX"],"gpt_icon":0},{"id":"2581099867","title":"CVRx Inc - May Offer and Sell up to $150 Mln in Securities - SEC Filing","url":"https://stock-news.laohu8.com/highlight/detail?id=2581099867","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2581099867?lang=en_us&edition=fundamental","pubTime":"2025-11-06 21:53","pubTimestamp":1762437205,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251106:nFWN3WI0ZY:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4082","CVRX","BK4539"],"gpt_icon":0},{"id":"2581966570","title":"CVRx price target raised to $11 from $9 at Canaccord","url":"https://stock-news.laohu8.com/highlight/detail?id=2581966570","media":"TIPRANKS","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2581966570?lang=en_us&edition=fundamental","pubTime":"2025-11-06 21:38","pubTimestamp":1762436283,"startTime":"0","endTime":"0","summary":"Canaccord raised the firm’s price target on CVRx (CVRX) to $11 from $9 and keeps a Buy rating on the shares. The firm said they reported Q3 results...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/cvrx-price-target-raised-to-11-from-9-at-canaccord-thefly?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/cvrx-price-target-raised-to-11-from-9-at-canaccord-thefly?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["CVRX"],"gpt_icon":0},{"id":"2581050506","title":"CVRx’s Strategic Advancements and Sales Growth Drive ‘Buy’ Rating","url":"https://stock-news.laohu8.com/highlight/detail?id=2581050506","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2581050506?lang=en_us&edition=fundamental","pubTime":"2025-11-06 17:35","pubTimestamp":1762421744,"startTime":"0","endTime":"0","summary":"William Blair analyst Brandon Vazquez has maintained their bullish stance on CVRX stock, giving a Buy rating on November 3. Brandon Vazquez has giv...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/ratings/cvrxs-strategic-advancements-and-sales-growth-drive-buy-rating-ratings?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":["rate","earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/ratings/cvrxs-strategic-advancements-and-sales-growth-drive-buy-rating-ratings?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["CVRX"],"gpt_icon":0},{"id":"2581056758","title":"U.S. RESEARCH ROUNDUP-Acadia Pharmaceuticals, Applovin, Centuri Holdings","url":"https://stock-news.laohu8.com/highlight/detail?id=2581056758","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2581056758?lang=en_us&edition=fundamental","pubTime":"2025-11-06 15:50","pubTimestamp":1762415430,"startTime":"0","endTime":"0","summary":"U.S. RESEARCH ROUNDUP-Acadia Pharmaceuticals, Applovin, Centuri Holdings Nov 6 (Reuters) - Wall Street securities analysts revised their ratings and price targets on several U.S.listed companies, incl","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251106:nL4N3WI0MF:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU2168564065.EUR","ACVA","LU2290526834.HKD","BK4139","BROS","LU2250418816.HKD","ANGI","CNMD","DT","CDRE","BALL","CTRI","CWAN","AKA","COR","COHR","BMBL","DEI","APP","CVRX","LU1069344957.HKD","CPAY","ADPT","LU1878469433.USD","CRL","AFG","CHH","DASH","SWX","DSGN","LU1721429741.USD","BK4209","SKY","AMPL","BK4536","ACAD","BK4187","ALL","BK4503","BSY","BHVN","CHYM","CNK","DIN","AIZ","BR","AVNT","ARCB"],"gpt_icon":1},{"id":"2581405354","title":"CVRx Inc : Canaccord Genuity Raises Target Price to $11 From $9","url":"https://stock-news.laohu8.com/highlight/detail?id=2581405354","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2581405354?lang=en_us&edition=fundamental","pubTime":"2025-11-06 15:03","pubTimestamp":1762412585,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251106:nFWN3WI0D4:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4082","CVRX","BK4539"],"gpt_icon":0},{"id":"2581039458","title":"CVRx Reports Revenue Growth Amid Strategic Expansion","url":"https://stock-news.laohu8.com/highlight/detail?id=2581039458","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2581039458?lang=en_us&edition=fundamental","pubTime":"2025-11-06 12:37","pubTimestamp":1762403865,"startTime":"0","endTime":"0","summary":"Cvrx, Inc. ( ($CVRX) ) has released its Q3 earnings. Here is a breakdown of the information Cvrx, Inc. presented to its investors. CVRx, Inc. is a ...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/cvrx-reports-revenue-growth-amid-strategic-expansion?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/cvrx-reports-revenue-growth-amid-strategic-expansion?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["CVRX"],"gpt_icon":0},{"id":"2581083759","title":"CVRx beats Q3 revenue expectations, gross margin climbs","url":"https://stock-news.laohu8.com/highlight/detail?id=2581083759","media":"Reuters","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2581083759?lang=en_us&edition=fundamental","pubTime":"2025-11-06 06:36","pubTimestamp":1762382171,"startTime":"0","endTime":"0","summary":"CVRx beats Q3 revenue expectations, gross margin climbsOverviewCVRx Q3 2025 revenue grows 10% yr/yr, beating analysts' expectationsU.S. revenue for Q3 2025 increases 10% yr/yr, driven by Barostim awar","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251105:nL1N3WH1GQ:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["CVRX","BK4539","BK4082"],"gpt_icon":0}],"profile":{"websiteUrl":"http://www.cvrx.com","stockEarnings":[{"period":"1week","weight":-0.0497},{"period":"1month","weight":-0.1224},{"period":"3month","weight":0.1199},{"period":"6month","weight":0.3703},{"period":"1year","weight":-0.3148},{"period":"ytd","weight":-0.3662}],"compareEarnings":[{"period":"1week","weight":-0.0017},{"period":"1month","weight":0.0271},{"period":"3month","weight":0.0254},{"period":"6month","weight":0.1452},{"period":"1year","weight":0.1612},{"period":"ytd","weight":0.1613}],"compareStock":{"symbol":"SPY","name":"SPDR S&P 500 ETF Trust"},"description":"CVRx, Inc., a commercial-stage medical device company, focuses on developing, manufacturing, and commercializing neuromodulation solutions for patients with cardiovascular diseases. The company offers Barostim, a neuromodulation device indicated to improve symptoms for patients with heart failure with reduced ejection fraction or systolic heart failure. It sells its products through direct sales force, as well as sales agents and independent distributors in the United States, Germany, and internationally. The company was incorporated in 2000 and is headquartered in Minneapolis, Minnesota.","yearOnYearQuotes":[{"month":1,"riseRate":0.25,"avgChangeRate":-0.108193},{"month":2,"riseRate":0.25,"avgChangeRate":-0.154532},{"month":3,"riseRate":0,"avgChangeRate":-0.152076},{"month":4,"riseRate":0.5,"avgChangeRate":-0.065187},{"month":5,"riseRate":0.25,"avgChangeRate":-0.143272},{"month":6,"riseRate":0.5,"avgChangeRate":0.203103},{"month":7,"riseRate":0.6,"avgChangeRate":0.080464},{"month":8,"riseRate":0.2,"avgChangeRate":-0.021267},{"month":9,"riseRate":0.4,"avgChangeRate":-0.009886},{"month":10,"riseRate":0.8,"avgChangeRate":0.147336},{"month":11,"riseRate":0.6,"avgChangeRate":0.134494},{"month":12,"riseRate":0.6,"avgChangeRate":0.121813}],"exchange":"NASDAQ","name":"CVRx, Inc.","nameEN":"CVRx, Inc."},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"deviceId":"web-server-community-laohu8-v3","version":"4.35.12","shortVersion":"4.35.12","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"CVRx, Inc.(CVRX),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","description":"Find the latest CVRx, Inc.(CVRX) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","keywords":"CVRx, Inc.,CVRX,CVRx, Inc.股票,CVRx, Inc.股票老虎,CVRx, Inc.股票老虎国际,CVRx, Inc.行情,CVRx, Inc.股票行情,CVRx, Inc.股价,CVRx, Inc.股市,CVRx, Inc.股票价格,CVRx, Inc.股票交易,CVRx, Inc.股票购买,CVRx, Inc.股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"CVRx, Inc.(CVRX),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","og_description":"Find the latest CVRx, Inc.(CVRX) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","og_image":"https://community-static.tradeup.com/news/9b6dafd60190235ae8e2c95f52c583a0"}}}

Introduction